Clearline Capital LP - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 177 filers reported holding HERON THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 1.13 and the average weighting 0.4%.

Quarter-by-quarter ownership
Clearline Capital LP ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$6,334,338
+104.8%
6,149,842
+130.7%
0.54%
+203.9%
Q2 2023$3,092,542
-2.0%
2,665,984
+27.6%
0.18%
-62.4%
Q1 2023$3,154,831
+23.1%
2,089,292
+103.9%
0.48%
+3.9%
Q4 2022$2,561,956
+357.5%
1,024,782
+2049.9%
0.46%
+76.8%
Q1 2020$560,000
+77.8%
47,667
+181.7%
0.26%
+68.2%
Q2 2019$315,000
-67.2%
16,920
-57.0%
0.15%
-69.3%
Q1 2019$961,000
-5.8%
39,3360.0%0.50%
-28.3%
Q4 2018$1,020,000
+4.7%
39,336
+27.9%
0.70%
+21.3%
Q3 2018$974,00030,7590.58%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TANG KEVIN C 21,288$250,00019.87%
TANG CAPITAL MANAGEMENT LLC 2,896,904$34,010,0004.78%
PFM Health Sciences, LP 2,481,917$29,138,0002.39%
Iron Triangle Partners LP 500,000$5,870,0002.27%
NEXPOINT ASSET MANAGEMENT, L.P. 777,599$9,129,0001.72%
Pekin Hardy Strauss, Inc. 588,732$6,912,0001.55%
First Light Asset Management, LLC 691,400$8,117,0001.39%
Congress Park Capital LLC 111,045$1,304,0001.18%
Mesirow Financial Investment Management, Inc. 15,135$178,0001.12%
Elk Creek Partners, LLC 509,174$5,978,0001.03%
View complete list of HERON THERAPEUTICS INC shareholders